Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan

International Journal of Clinical Oncology

Volumn 13, Issue 2, 2008, Pages 127-131

  Okusaka, Takuji ^a   Ito, Yoshinori ^a   Furuse, Junji ^b   Yamada, Shigeru ^c   Ishii, Hiroshi ^d   Shibuya, Keiko ^e   Ioka, Tatsuya ^f   Shinchi, Hiroyuki ^g  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Gemcitabine; Pancreatic cancer; S 1

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; STREPTOZOCIN;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; JAPAN; MAINTENANCE DRUG DOSE; MONOTHERAPY; OUTCOME ASSESSMENT; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DEPTH DOSE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG COMBINATIONS; HUMANS; JAPAN; OXONIC ACID; PANCREATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEGAFUR;

EID: 43449137260     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0739-x     Document Type: Conference Paper

References (29)